Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 28, 2003. The report details corporate actions regarding share re-purchases and updates on directors' interests in company shares and employee benefit plans.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial data disclosed relates to a share re-purchase transaction:
- Shares Purchased: 810,000 ordinary shares
- Purchase Date: May 27, 2003
- Price per Share: 1,222.91p
- Purpose: Cancellation of shares
Material Changes
The filing reports the following material changes and transactions:
- Share Capital Reduction: Execution of a share buyback authorized by shareholders at the Annual General Meeting on May 19, 2003.
- Directors' Interests (GSK Trust): On May 20, 2003, the GSK Trust transferred 38,790 ordinary shares to a participant in the SmithKline Beecham Mid Term Incentive Plan. Directors Dr. J-P Garnier and Mr. J D Coombe hold interests in the trust as potential beneficiaries.
- Directors' Interests (US Retirement Plan): The GlaxoSmithKline US Retirement Savings Plan saw an increase in Ordinary Share ADRs held. Holdings rose from 18,593,843 to 18,594,217 on May 22, 2003 (avg. price $41.40), and further to 18,740,185 on May 23, 2003 (avg. price $40.60). Director Dr. J P Garnier is a potential beneficiary of this fund.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items beyond the routine disclosure of the share buyback and director interest updates.
Key Facts for Investor Verification
- Verify the total number of shares remaining in the buyback program following the purchase of 810,000 shares.
- Confirm the impact of the share cancellation on the company's total share count and earnings per share.
- Review the full Annual General Meeting minutes from May 19, 2003, to understand the total authority granted for share re-purchases.
- Check subsequent filings for any further changes in the US Retirement Savings Plan holdings or GSK Trust distributions.